| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/29/2005 | WO2005090972A1 Biological substance analyzing kit, analyzer and analyzing method |
| 09/29/2005 | WO2005090971A1 Anti-lipid rafts antibodies |
| 09/29/2005 | WO2005090970A1 Device and method for detecting analytes by visualization and separation of agglutination |
| 09/29/2005 | WO2005090969A1 Analysis element for use in method of testing specimen |
| 09/29/2005 | WO2005090968A1 Tat-based immunomodulatory compositions and methods of their discovery and use |
| 09/29/2005 | WO2005090967A2 The use of gametes and pre-implanted embryos for determining the toxicity of biologically active compounds |
| 09/29/2005 | WO2005090966A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard) |
| 09/29/2005 | WO2005090965A1 Rice extract, method of preparing the same and method of discriminating breed with use thereof |
| 09/29/2005 | WO2005090964A1 Apparatus for inspecting food items |
| 09/29/2005 | WO2005090963A1 Method of identifying sugar chain structure and apparatus for analyzing the same |
| 09/29/2005 | WO2005090961A1 Measuring method in which biomolecule configuration and information are detected using is-fet and system therefor |
| 09/29/2005 | WO2005090957A1 Connector cable for probe |
| 09/29/2005 | WO2005090948A2 Composite organic-inorganic nanoclusters |
| 09/29/2005 | WO2005090945A1 Method for imaging and differential analysis of cells |
| 09/29/2005 | WO2005090606A2 Identification of toxic nucleotide sequences |
| 09/29/2005 | WO2005090604A1 Method of detecting gene mutation and kit for detecting gene mutation |
| 09/29/2005 | WO2005090594A1 Diagnostics and therapeutics for diseases associated with nima (never in mitosis gene a)-related kinase 3 (nek3) |
| 09/29/2005 | WO2005090593A1 Host markers for diagnosis of equine protozoal myeloencephalitis and sarcocystis neurona infection |
| 09/29/2005 | WO2005090580A1 Using nonhuman animal model, method of measuring transcription activity, method of measuring cell quantity and method of measuring tumor volume |
| 09/29/2005 | WO2005090573A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 09/29/2005 | WO2005090569A1 Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof |
| 09/29/2005 | WO2005090563A1 Solvent for dissolving nucleic acid, nucleic acid-containing solution and method of preserving nucleic acid |
| 09/29/2005 | WO2005090561A1 Method of screening activation inhibitor for macrophage cell |
| 09/29/2005 | WO2005090546A1 Chip production, hybridization and data interpretation for antibody and protein microarrays |
| 09/29/2005 | WO2005090486A2 Surface modified carbon products and their applications |
| 09/29/2005 | WO2005090404A2 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 09/29/2005 | WO2005090399A1 Antibody recognizing the proliferation/differentiation of various types of cells and method of evaluating proliferation/differentiation by using the antibody |
| 09/29/2005 | WO2005090398A1 Genes and polypeptides relating to prostate cancers |
| 09/29/2005 | WO2005090390A1 Novel assay for the separation and quantification of hemagglutinin antigens |
| 09/29/2005 | WO2005090378A1 Ligands of the molecule fit (agt-121) and their pharmaceutical use |
| 09/29/2005 | WO2005089944A2 Microfluidic chip |
| 09/29/2005 | WO2005089816A1 Methods for uniformly treating biological samples with electromagnetic radiation |
| 09/29/2005 | WO2005089801A1 Method of preventing ultraviolet ray-induced apoptosis |
| 09/29/2005 | WO2005089735A2 Compositions and methods for treating lung cancer |
| 09/29/2005 | WO2005089527A2 Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores |
| 09/29/2005 | WO2005089524A2 Compositions and methods for detection of single molecules |
| 09/29/2005 | WO2005089518A2 Uch-l1 expression and cancer therapy |
| 09/29/2005 | WO2005089509A2 High throughput assay systems and methods for identifying agents that alter expression of cellular proteins |
| 09/29/2005 | WO2005089454A2 Fluorescence polarization assay |
| 09/29/2005 | WO2005089442A2 Inhibitors of gob-4 protein as asthma therapeutics |
| 09/29/2005 | WO2005089415A2 Stabilization of self-assembled monolayers |
| 09/29/2005 | WO2005089409A2 Sensor constructs and detection methods |
| 09/29/2005 | WO2005089308A2 Gene expression and polymorphisms that influence lung cancer susceptibility |
| 09/29/2005 | WO2005089254A2 A method of evaluating freshness of a fish product |
| 09/29/2005 | WO2005089210A2 Systems and methods for collecting and analysing tear film osmolarity data |
| 09/29/2005 | WO2005089156A2 Methods for the indentification of inhibitors of histidinol dehydrogenase as antibiotics |
| 09/29/2005 | WO2005089082A2 Assay device and method |
| 09/29/2005 | WO2005089080A2 Method and kit for screening, pharmaceutical compositions and method for treatment of autoimmune disorders |
| 09/29/2005 | WO2005089045A2 Prognostic methods for congestive heart failure |
| 09/29/2005 | WO2005089043A2 Prostate stem cell |
| 09/29/2005 | WO2005078076A3 Tpl2 and its expression |
| 09/29/2005 | WO2005074460A3 Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods |
| 09/29/2005 | WO2005074088A3 Environmental fuse |
| 09/29/2005 | WO2005071418A3 Diagnostic and therapeutic use of the human dax- 1 gene and protein for neurodegenerative diseases |
| 09/29/2005 | WO2005070037A3 Automated media optimization technology |
| 09/29/2005 | WO2005067692A3 Detection and quantification of analytes in solution using polymers |
| 09/29/2005 | WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 09/29/2005 | WO2005063335A3 MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS |
| 09/29/2005 | WO2005062053A3 Method and device for detecting feline immunodeficiency virus |
| 09/29/2005 | WO2005059165A3 Methods for detecting bacterial pathogens |
| 09/29/2005 | WO2005056807A3 Bovine adeno-associated viral (baav) vector and uses thereof |
| 09/29/2005 | WO2005055813A3 Interaction of nmda receptor with the protein tyrosine phosphatase step in psychotic disorders |
| 09/29/2005 | WO2005054811A3 Method and apparatus for ultrasonic determination of hematocrit and hemoglobin concentrations |
| 09/29/2005 | WO2005052592A3 Methods for diagnosis, stratification, and monitoring of alzheimer’s disease |
| 09/29/2005 | WO2005051985A3 Methods for purifying pertussis toxin and peptides useful therefor |
| 09/29/2005 | WO2005050667A3 System and method for estimating helium production in stainless steel core shrouds of nuclear reactors |
| 09/29/2005 | WO2005047864A3 Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules |
| 09/29/2005 | WO2005046616A3 Viral propagation system and uses thereof |
| 09/29/2005 | WO2005040758A3 Use of pirfenidone in therapeutic regimens |
| 09/29/2005 | WO2005038005A9 Shc proteins as therapeutic targets in proliferative diseases |
| 09/29/2005 | WO2005029066A3 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 09/29/2005 | WO2005028516A3 Albumin-binding derivatives of therapeutic peptides |
| 09/29/2005 | WO2005026739A3 Increasing the bioavailability of carotenoids by enzymatic hydrolysis of the corresponding fatty acid esters |
| 09/29/2005 | WO2005023295A3 Naturally processed immunodominant peptides derived from neisseria meningitidis porin a protein and their use |
| 09/29/2005 | WO2005023205A3 Compositions and methods for yersinia pestis treatment |
| 09/29/2005 | WO2005012329A3 Kinase and phosphatase assays |
| 09/29/2005 | WO2005010483B1 Sensor arrangement |
| 09/29/2005 | WO2004113552A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 09/29/2005 | WO2004103149B1 Genes encoding single chain human leukocyte antigen e (hla-e) proteins to prevent natural killer cell-mediated cytotoxicity |
| 09/29/2005 | WO2004092338A3 Compositions, splice variants and methods relating to cancer specific genes and proteins |
| 09/29/2005 | WO2004085618A3 Method of screening for target ligands |
| 09/29/2005 | WO2004076632A3 Methods of screening for trpm5 modulators |
| 09/29/2005 | WO2004063355A3 Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer |
| 09/29/2005 | WO2004050682A3 Phosphospecific pak antibodies and diagnostic kits |
| 09/29/2005 | WO2004043385A3 Methods and compositions for prostate epithelial cell differentiation |
| 09/29/2005 | WO2004037991A3 Prkcb1 as modifier of branching morphogenesis and methods of use |
| 09/29/2005 | WO2004031365A3 Sulfatases and methods of use thereof |
| 09/29/2005 | WO2004002308A3 Management of gastro-intestinal disorders |
| 09/29/2005 | WO2002079491A3 Method for correlating gene expression profiles with protein expression profiles |
| 09/29/2005 | US20050216964 Using swine organs devoid of porcine endogenous retrovirus (PERV) for xenotransplantation and treatment of end-stage organ diseases |
| 09/29/2005 | US20050216961 Cancer associated protein kinases and their uses |
| 09/29/2005 | US20050216960 Using tumor necrosis factor related apoptosis inducing ligand receptor (TRAIL-R) to identify modulators of dendritic cell immune response |
| 09/29/2005 | US20050216520 Systems and methods for versioning based triggers |
| 09/29/2005 | US20050216226 Method for determining physical properties of wood |
| 09/29/2005 | US20050216223 Method of evaluating the capillary pressure curve of an underground deposit rocks based on rock cuttings measurements |
| 09/29/2005 | US20050216208 Diagnostic decision support system and method of diagnostic decision support |
| 09/29/2005 | US20050216207 Artificial intelligence and global normalization methods for genotyping |
| 09/29/2005 | US20050216205 Method for measuring surface plasmon resonance |
| 09/29/2005 | US20050216204 Method and apparatus for tissue modeling |
| 09/29/2005 | US20050216203 System and method for providing optimal concentrations for medication infusions |